The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,822.60, is for the delivery of Insulin Aspart 100 Unit/ML Vials 10ML to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,240.20 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of insulin aspart 100 unit/ml pen 3ml to support military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,467.84 contract is for the supply of Insulin Aspart Pro Mix 70-30 3mL, a pharmaceutical product, with a completion date of February 15, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,171.57 firm-fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL Vial, 10mL. The contract has an ultimate completion date of August 23, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide 4,563,557,490 units of insulin aspart 100 unit/mL pens. The $7,975.68 contract has a completion date of February 6, 2024 and was awarded on February 5, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, valued at $2,537.05. The contract is for the supply of 4,563,982,171 units of Insulin Glargine-yfgn U100 Pen, a specialty pharmaceutical product, with a period of performance through March 18, 2024. This delivery order is placed under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA,...
The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $12,827.15 firm fixed-price delivery order contract for 4,564,313,868 units of insulin aspart 100 unit/mL pen, 3mL. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a for-profit global pharmaceutical sourcing and distribution company. The contract, valued at $10,021.86, is for the delivery of Insulin Aspart 100 unit/ml vials with a completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor and this order is placed under a larger indefinite delivery contract (IDC)...
This federal contract award, valued at $3,013.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Insulin Aspart 100 Unit/mL medication, a critical pharmaceutical product used in the treatment of diabetes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,474.68 firm fixed-price delivery order is for the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML, a critical medical commodity used in the treatment of diabetes. The contract has an ultimate completion date of May 1, 2024 and was awarded on April 30, 2024. This delivery order is part of a larger $999,999,999...